13D/13G Filings - Dianthus Therapeutics Inc. (DNTH)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-24
4:08 pm
Purchase
2025-03-1713GDianthus Therapeutics, Inc.
DNTH
Deep Track Capital, LP2,357,702
7.340%
2,357,702increase
(New Position)
Filing
History
2025-03-19
9:30 pm
Purchase
2025-03-1713DDianthus Therapeutics, Inc.
DNTH
Avidity Partners Management LP3,378,939
9.900%
448,689increase
(+15.31%)
Filing
History
2025-02-14
6:32 pm
Sale
2024-12-3113GDianthus Therapeutics, Inc.
DNTH
RA Capital Management, L.P.2,866,733
9.400%
-128,290decrease
(-4.28%)
Filing
History
2025-02-14
07:54 am
Sale
2024-12-3113GDianthus Therapeutics, Inc.
DNTH
BCLS Fund III Investments, LP2,689,707
8.800%
-302,321decrease
(-10.10%)
Filing
History
2025-02-05
5:42 pm
Purchase
2024-12-3113GDianthus Therapeutics, Inc.
DNTH
Octagon Capital Advisors LP2,110,167
7.100%
363,500increase
(+20.81%)
Filing
History
2024-12-03
9:19 pm
Purchase
2024-11-2913DDianthus Therapeutics, Inc.
DNTH
Avidity Partners Management LP2,930,250
9.900%
7,427increase
(+0.25%)
Filing
History
2024-11-22
4:41 pm
Purchase
2024-11-1513GDianthus Therapeutics, Inc.
DNTH
TCG Crossover GP II, LLC1,501,624
5.100%
1,501,624increase
(New Position)
Filing
History
2024-11-14
5:48 pm
Sale
2024-09-3013GDianthus Therapeutics, Inc.
DNTH
5AM Partners VII, LLC 1,027,711
3.500%
-654,873decrease
(-38.92%)
Filing
History
2024-11-14
5:47 pm
Purchase
2024-09-3013GDianthus Therapeutics, Inc.
DNTH
Venrock Healthcare Capital Partners III, L.P.1,744,373
5.900%
816,667increase
(+88.03%)
Filing
History
2024-11-08
5:31 pm
Unchanged
2024-09-3013GDianthus Therapeutics, Inc.
DNTH
BlackRock Inc.
BLK
1,644,819
5.600%
0
(Unchanged)
Filing
History
2024-10-24
2:02 pm
Purchase
2024-09-3013GDianthus Therapeutics, Inc.
DNTH
BlackRock Inc.
BLK
1,644,819
5.600%
1,644,819increase
(New Position)
Filing
History
2024-10-11
4:02 pm
Purchase
2024-09-3013GDianthus Therapeutics, Inc.
DNTH
Octagon Capital Advisors LP1,746,667
6.000%
1,746,667increase
(New Position)
Filing
History
2024-09-12
8:45 pm
Unchanged
2024-03-2113DDianthus Therapeutics, Inc.
DNTH
Viridian LLC1,090,283
3.720%
0
(Unchanged)
Filing
History
2024-04-01
6:34 pm
Sale
2024-04-0113DDianthus Therapeutics, Inc.
DNTH
Fairmount Funds Management LLC2,957,385
9.990%
-3,362decrease
(-0.11%)
Filing
History
2024-02-14
4:58 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
Citadel Advisors LLC2,880
0.000%
2,880increase
(New Position)
Filing
History
2024-02-14
4:16 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
5AM Partners VII, LLC 1,682,584
5.700%
200,264increase
(+13.51%)
Filing
History
2024-02-14
4:15 pm
Unchanged
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
Third Rock Ventures IV L.P.0
0.000%
0
(Unchanged)
Filing
History
2024-02-09
4:10 pm
Purchase
2023-12-3113GDianthus Therapeutics, Inc.
DNTH
GV 2016, L.P.208,697
1.400%
208,697increase
(New Position)
Filing
History
2024-02-02
4:32 pm
Purchase
2024-01-2413GDianthus Therapeutics, Inc.
DNTH
BCLS Fund III Investments, LP2,992,028
9.990%
2,992,028increase
(New Position)
Filing
History
2024-02-01
6:22 pm
Purchase
2024-01-2213GDianthus Therapeutics, Inc.
DNTH
RA Capital Management, L.P.2,995,023
9.990%
2,995,023increase
(New Position)
Filing
History
Goto 0, 1, 2, Next